Andranik Gevorgyan

Exxon Mobil Corp’s stock has had a rapid “V-shape” recovery, following the freefall of the financial markets caused by the first wave of the COVID-19 pandemic’s blow to the global economy. Since July 2020, the XOM market value has been on the constant rise with a few smaller pullbacks in between. The company’s stock gained over 230% through this rally, reaching its price peak of around USD 114 per share in November 2022. There are different views on where will XOM be moving in the short- and long-term future, however, most analysts have reached a consensus that the stock is currently a buy, projecting a continued increase in its price at the market in a long run.

Inovio is a biotech company focusing on the development and manufacturing of DNA-based product lines to target different kinds of viruses including but not limited to COVID, Zika, Ebola, etc. The stock price of the company has been losing value for several years now since the company is exhausting money due to high research and development costs. The expectation is for the company to drain its cash in case of a lack of positive outcomes from the product pipelines or a lack of additional funding which will cause a further decline in stock price.

Ocugen, Inc.’s stock price is likely to trade around the same area for the foreseeable future with an eye on positive headlines that might fuel the stock price growth. While some analysts predict a significant price increase in the next year the stock price remains quite sensitive to the headlines and those headlines are not expected till the end of the first quarter of 2023.

Petroleo Brasileiro is one of the largest global manufacturers and suppliers of oil and gas products globally. It has strong financials, but due to the volatile sector that the company is in, the stock price was moving up and down in recent years and will be doing so in the future. It is currently benefiting from the global energy crisis and would continue to do so if there are no political or regulatory decisions to fight against the energy price increases.

Porsche one of the recent and largest IPOs in the European market had significant price growth since its debut on the German stock exchange. The company has strong fundamentals and a robust brand reputation which will help it to grow its revenues into the future while at the same time supporting positive price action. The only issues currently in the market that are affecting not only Porsche but also most of the companies who are dependent on raw materials or production facilities overseas are supply chain issues. This is the only negative factor currently visible on the horizon and the market is waiting to see further developments on this front to make a decision in terms of the direction of the stock price. Therefore, most of the analysts covering the stock suggest holding the stock with the target price range of EUR 90 - 110 per share.

Stellantis N.V. was established through the merger of two large automakers - Fiat Chrysler Automobiles and the Peugeot Group. The headquarter of the new company are located in the Netherlands and it offers world-known cars under the brands Chrysler, Fiat, Jeep, Opel, Peugeot, etc. to name a few. Trading under the ticker STLA on NYSE and other stock exchanges globally has lost around 10% of its market value since the merger in mid-January 2021. Most recently, in the last 6 months, the stock was trading between USD 11 and 16 per piece and is currently hovering in the area of USD 14.5. There are different projections on where the STLA will move from here on, however, the majority of covering analysts have reached a consensus on this stock being a buy at its current price. Most of the forecasts hint at the growth prospects of STLA’s market value in a mid- to long-term horizon.